NCT05878951View on ClinicalTrials.gov

Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 13, 2023

Primary Completion Date

October 1, 2025

Study Completion Date

August 24, 2026

Conditions
Urinary IncontinenceOveractive Bladder SyndromeOveractive BladderUrologic Diseases
Interventions
DRUG

OnabotulinumtoxinA

Intra-detrusor OnabotulinumtoxinA is commonly known as botox

Trial Locations (1)

60611

RECRUITING

Northwestern Medicine, Chicago

All Listed Sponsors
collaborator

University of Calgary

OTHER

collaborator

Ohio State University

OTHER

collaborator

University of Alberta

OTHER

lead

Northwestern University

OTHER